Inactive Instrument
Invitae Corporation Stock Mexican S.E.
Stocks
NVTA *
US46185L1035
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Spirito
CEO | Chief Executive Officer | - | - |
Hoki Luk
IRC | Investor Relations Contact | - | - |
Robert Guigley
PRN | Corporate Officer/Principal | - | 05/09/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -8.09% | - | - | 85.95K | ||
| -3.19% | -3.19% | +44.60% | +87.98% | 72.13B | ||
| +3.57% | -10.40% | +5.18% | +56.45% | 49.41B | ||
| +1.19% | +1.06% | +5.03% | +33.24% | 47.24B | ||
| -6.35% | -8.63% | +293.39% | +651.28% | 40.32B | ||
| +0.30% | -0.71% | +29.05% | +30.33% | 42.61B | ||
| -3.82% | -2.41% | -0.27% | +101.36% | 39.81B | ||
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | ||
| -3.35% | -4.95% | -13.38% | -17.22% | 23.13B | ||
| +2.84% | +7.44% | +17.43% | -0.49% | 21.09B | ||
| Average | -0.45% | -3.66% | +43.17% | +110.36% | 40.7B | |
| Weighted average by Cap. | -0.77% | -3.85% | +46.57% | +118.55% |
Employees
1,700
















